Q: Follow-up on my earlier post today relevant to a possible reason for COVALON's 10% jump in stock price: The Zacks report a COV director sent to investors this morning (as an email attachment) is dated: March 18, 2019, and was authored by Brian Marckx, CFA, with Zacks Small Cap Research. While there may be an old Zacks report out there, this one appears to be new.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Jeffrey Mandel (a director on Covalon's Board) sent one of his periodic e-mails directly to COV investors. Today's message included a PDF attachment of a 25pp research document COV apparently commissioned from Zacks Small Cap Research in Chicago. Unsurprisingly, the analysis is glowing, which stated, in part, "We forecast Covalon to generate revenue and EPS of C$53.4M and C$0.13 in 2019 and C$64.5M and C$0.30 in 2020. We value Covalon using a combination of P/S and P/E methodologies. Based on analyst's revenue and EPS estimates of publicly traded companies in focused on wound care and medical supplies, infection control and vascular products, we calculate fair value of Covalon at ~C$11.2/share, or US$8.50 based on current exchange rates."
Q: Hi Team,
Could you tell us the story behind today's 10% jump please.
Thanks!
Could you tell us the story behind today's 10% jump please.
Thanks!
Q: What is your opinion on VRTX?
Q: In reference to your answer to Roy on March 29. While I appreciate your answer to the question asked, it leaves me as an existing stockholder wondering if you are implying a sell recommendation above $15.00
Hope you understand my thought on this.
Thanks
John
Hope you understand my thought on this.
Thanks
John
Q: Put in an order to SIS this am. It ran away from me. Based on valuation what would you consider a fair bid for this stock?
Q: $17.28p/p, now 3.5% position. Positive market response to Q results even though missed estimated eps. Is it time for me to add? Thanks for u usual great services & views
Q: With the new agreement with Glencore how do you feel about the future of NIF.UN? What has to happen to restart the dividend?
I would appreciate your thoughts on PRN also.
Thank you,
Bob
I would appreciate your thoughts on PRN also.
Thank you,
Bob
Q: May I have your opinion on the latest results? Thank you.
Q: IRTC has plunged today.. what has caused this?
Thanks,
Susan
Thanks,
Susan
Q: I own 6800 shares of Knight at an average cost of $8.10. This amounts to about 2% of my portfolio. I could sell it all, sell half or do nothing. What do you see for Knight in the next 5 years. Should I be looking elsewhere? Thank You.
Q: do you have a opinion on VCAN, previously BLVD, and before that CXV. It has gone through several transformations do you like the current version and what are it's prospects ? Is it worth a gamble? If you have a favourable opinion how long to wait before seeing results.
Thank you
Thank you
Q: Hi! I was wondering if you recommend SIS (Savaria) before their earnings on the 27th, or if you have an opinion on it. I bought at 13.07 last week, but I am a bit nervous about a drop come their earnings. Any thought you have on it would be appreciated!
Q: Never fall in love with a stock, i feel i5 has on this one. Say treating it like cash for buying an idea later, why not buy a solid income stock with a good dividend and treat it as a cash account as you say, at least you are getting something. Speaking of cash rich companies, how about buying Apple and hold it for cash, and also a dividend, no shortage of cash there.
Q: Hello 5i team. I have a 6% holding in the stock. Is this a good time to take in some profit by selling 1/2 position? What is your take on holding long term?
Q: To take Goodman's "grandchildren" analogy to heart, then, ... I'm assuming he's telling us to bail if we don't have grandkids? : /
What if our grandkids are already taken care of, and we'd like to see better results now?
Five years seems to be an awfully long time for compost to ferment, in my mind. I'm an organic gardener, so no disrespect intended here. ; )
Your thoughts, please, on his silly analogy. This slow-burning genius seems to be fizzling out, like a dud firecracker. Surely investors deserve a little something for being so patient -- maybe even a little respect.
What if our grandkids are already taken care of, and we'd like to see better results now?
Five years seems to be an awfully long time for compost to ferment, in my mind. I'm an organic gardener, so no disrespect intended here. ; )
Your thoughts, please, on his silly analogy. This slow-burning genius seems to be fizzling out, like a dud firecracker. Surely investors deserve a little something for being so patient -- maybe even a little respect.
Q: yes, BIIB made a disappointing announcement yesterday and the stock price dropped like heavy rock, down 30%....sure it is a growth company...but going forward, I am not sure why I should remain with a position in it......what is your take now for the future?.......and should I hold for now until it settles down, if I decide to sell.........thanks.....Tom
Q: I hate lawsuits. Been holding Knight at a huge loss waiting for the big payday. I know you do not act as a financial advisor but would YOU hang on to your knight shares? Lawsuits take forever unless this Medison guy settles. This will distract from business at hand. Yes, no? Thanks for your views and sage advice.
Q: Cipher's quarterly report highlights transitions and strategic positioning for long term growth, also debt reduction. Their list of 2018 year end highlights appears impressive but does it read that way to you? This company looks busy for their size but what significants do you take from the list of 2019 anticipated milestones? Would you dip a toe in here? Finally how similar are CPH and GUD in strategic growth plans?
Q: Opinion of value after last report, and responding share price movement?